object
improv
diagnosi
part
laboratori
surveil
taiwan
influenzalik
ill
ili
surveil
conduct
use
new
multiplex
pcr
assay
filmarray
result
compar
convent
method
studi
perform
winter
month
method
throat
swab
patient
ili
present
physician
sentinel
practic
collect
influenza
season
result
total
sampl
test
posit
filmarray
respiratori
panel
forti
percent
influenza
viru
subtyp
viru
major
epidem
strain
howev
nearli
ili
case
seen
sentinel
site
caus
noninfluenza
pathogen
result
filmarray
assay
cell
cultur
ident
assay
sensit
rapid
influenza
diagnost
test
genet
analys
reveal
new
influenza
variant
belong
novel
subclad
conclus
filmarray
assay
facilit
urgent
test
laboratori
surveil
common
viral
bacteri
respiratori
pathogen
studi
demonstr
use
highli
sensit
assay
use
clinic
sampl
feasibl
applic
worldwid
may
lead
increas
rate
diagnosi
viral
infect
improv
patient
outcom
particular
reduct
overus
antibiot
antivir
acut
respiratori
infect
often
caus
virus
import
caus
morbid
mortal
taiwan
chang
et
al
chiu
et
al
kim
et
al
tsai
et
al
past
influenza
season
mani
sever
case
death
report
among
middleag
popul
group
major
socioeconom
impact
therefor
taiwan
center
diseas
control
cdc
expand
scope
provid
free
influenza
vaccin
children
age
month
year
pregnant
women
women
within
month
give
birth
adult
age
year
atrisk
individu
chronic
medic
condit
individu
rare
diseas
major
illnessesinjuri
health
care
public
health
personnel
poultri
farmer
anim
health
inspector
individu
bodi
mass
index
bmi
kgm
resid
personnel
nurs
institut
campaign
increas
flu
vaccin
coverag
total
popul
taiwan
howev
clinic
sign
symptom
upper
respiratori
infect
similar
mani
differ
virus
make
etiolog
diagnosi
base
clinic
present
alon
difficult
sometim
lead
delay
therapeut
manag
abil
detect
virus
improv
avail
pcr
sever
new
virus
identifi
poutanen
et
al
van
den
hoogen
et
al
zaki
et
al
use
sensit
method
led
increas
rate
diagnosi
viral
infect
improv
patient
outcom
autom
multiplex
pcr
devic
filmarray
respiratori
panel
viral
pathogen
bacteri
pathogen
detect
close
system
requir
min
handson
time
approxim
h
instrument
time
aim
studi
determin
whether
result
provid
new
multiplex
pcr
techniqu
would
use
applic
public
health
laboratori
surveil
influenzalik
ill
ili
throat
swab
collect
patient
ili
influenza
season
novemb
januari
taipei
taiwan
taipei
citi
capit
citi
account
approxim
one
tenth
total
popul
taiwan
ili
defin
sudden
onset
fever
c
cough
andor
sore
throat
without
known
caus
influenza
biolog
materi
obtain
studi
use
standard
diagnost
procedur
request
patient
physician
specif
sampl
method
use
modif
made
sampl
protocol
accord
local
regul
procedur
requir
specif
patient
consent
convent
method
use
clinic
sampl
sampl
inocul
mdck
rd
vero
hela
cell
line
cell
growth
evalu
mem
minimum
essenti
medium
contain
vv
fetal
bovin
serum
antibiot
co
humidifi
incub
day
cytopath
effect
cpe
observ
indirect
immunofluoresc
assay
ifa
use
monoclon
antibodi
merck
millipor
cat
no
influenza
b
virus
parainfluenza
viru
type
respiratori
syncyti
viru
rsv
adenoviru
enteroviru
also
perform
furthermor
convent
pcr
use
detect
rhinoviru
enteroviru
coronaviru
chlamydia
pneumonia
mycoplasma
pneumonia
report
previou
studi
freymuth
et
al
rose
et
al
clinic
sampl
analyz
use
biofir
filmarray
respiratori
panel
biofir
diagnost
salt
lake
citi
ut
usa
panel
use
multiplex
pcr
assay
detect
respiratori
diagnost
poritz
et
al
pairwis
align
perform
use
bioedit
hall
multipl
sequenc
align
perform
use
muscl
edgar
align
sequenc
manual
inspect
edit
phylogeni
reconstruct
evalu
infer
maximum
likelihood
method
mega
tamura
et
al
use
transitiontransvers
ratio
alpha
paramet
gamma
distribut
estim
maximum
likelihood
treepuzzl
softwar
schmidt
et
al
robust
maximum
likelihood
tree
evalu
static
bootstrap
analysi
bootstrap
sampl
genom
sequenc
vaccin
strain
recommend
world
health
organ
use
refer
sequenc
retriev
nation
center
biotechnolog
inform
ncbi
influenza
viru
resourc
http
wwwncbinlmnihgovgenomesflufluhtml
global
initi
share
influenza
data
gisaid
http
wwwgisaidorg
hemagglutinin
nucleotid
sequenc
influenza
virus
isol
studi
deposit
gisaid
databas
assign
access
number
novemb
januari
total
sampl
three
sentinel
site
taipei
citi
collect
sent
taiwan
cdc
among
subject
male
femal
rang
age
year
common
clinic
manifest
fever
c
overal
total
sampl
posit
respiratori
pathogen
dual
infect
found
patient
sampl
influenza
aposit
case
one
case
noninfluenza
virus
rvhev
parainfluenza
viru
human
coronaviru
mycoplasma
pneumonia
human
metapneumoviru
human
adenoviru
tabl
result
filmarray
assay
rapid
diagnost
test
esplin
influenza
bn
viral
cultureifa
shown
tabl
influenzaposit
case
rapid
test
identifi
filmarray
identifi
posit
predict
valu
rapid
test
show
lower
sensit
filmarray
assay
sampl
posit
filmarray
also
yield
posit
isol
cell
cultur
combin
ifa
method
result
filmarray
assay
cell
cultur
ident
although
rel
preval
rate
influenza
virus
vari
season
season
influenza
viru
major
epidem
strain
isol
studi
period
phylogenet
analysi
influenza
viru
gene
indic
recent
circul
influenza
virus
taiwan
fell
clade
major
repres
new
drift
genet
type
subclad
figur
three
new
phylogenet
subclad
emerg
one
subdivis
two
virus
subclad
predomin
region
world
recent
year
virus
chang
gene
refer
subclad
harvala
et
al
world
health
organ
european
centr
diseas
prevent
control
ecdc
antigen
character
virus
continu
technic
challeng
due
low
undetect
hemagglutin
activ
describ
mani
studi
lednicki
et
al
lin
et
al
skowronski
et
al
taiwan
virus
first
detect
earli
addit
two
influenza
isol
identifi
two
addit
substitut
form
clade
belong
novel
subclad
cluster
new
subclad
emerg
propos
london
recent
harvala
et
al
studi
first
evalu
suitabl
filmarray
multiplex
pcr
method
survey
respiratori
pathogen
among
patient
ili
influenza
season
taiwan
influenza
surveil
taiwan
base
sentinel
physician
laboratori
isol
influenza
virus
lin
et
al
howev
respiratori
virus
caus
upper
respiratori
tract
infect
rate
similar
influenza
viru
account
substanti
percentag
ili
case
fowlk
et
al
otomaru
et
al
data
studi
show
around
ili
case
seen
sentinel
site
caus
influenza
viru
infect
even
influenza
season
still
mani
respiratori
pathogen
virus
also
bacteria
cocircul
influenza
viru
note
hrv
hev
part
noninfluenza
infect
taiwan
data
laboratori
investig
show
case
caus
enterovirus
rate
posit
hrvhev
infect
present
studi
higher
report
previou
studi
liao
et
al
lin
et
al
ili
surveil
conduct
taiwan
influenza
season
present
studi
includ
involv
respiratori
virus
result
suggest
need
sensit
specif
laboratori
diagnost
system
along
clinician
prescript
avoid
misus
overus
medic
resourc
spread
communic
diseas
regard
season
influenza
viru
activ
previou
studi
shown
possibl
captur
signific
proport
influenza
viru
divers
taiwan
well
earli
emerg
new
phylogenet
lineag
antigen
variant
neighbor
countri
like
progenitor
epidem
strain
follow
season
chiu
et
al
lin
et
al
studi
concurr
exist
european
strain
subclad
identifi
harvala
et
al
genet
observ
show
epidem
strain
serotyp
isol
taiwan
compar
strain
isol
elsewher
howev
origin
effect
strain
introduc
outsid
taiwan
could
address
studi
remain
unclear
taiwan
import
region
viral
divers
howev
geograph
posit
taiwan
provid
ideal
environ
viral
migrat
tropic
temper
region
furthermor
among
countri
east
asia
taiwan
particularli
highli
interconnect
world
via
air
travel
thu
continu
monitor
taiwanes
isol
may
provid
complet
profil
viral
antigen
genet
evolut
pattern
may
import
assist
earli
predict
potenti
new
region
pandem
strain
studi
limit
first
surveil
implement
three
sentinel
site
surround
area
taipei
citi
may
limit
abil
gener
find
entir
countri
second
case
neg
result
test
pathogen
test
perform
identifi
etiolog
agent
includ
bacteria
third
possibl
observ
limit
particular
strain
respiratori
virus
circul
studi
region
larger
studi
involv
specimen
differ
geograph
area
would
help
assess
reliabl
valid
studi
find
facil
avail
rapid
diagnosi
microorgan
laboratori
includ
autom
nuclisen
easymag
instrument
marci
letoil
franc
nucleic
acid
extract
lightcycl
thermal
cycler
roch
molecular
biochem
realtim
pcr
detect
perkin
elmer
thermocycl
appli
biosystem
forest
citi
ca
usa
convent
rtpcr
reaction
total
runtim
approxim
h
cost
test
eight
specimen
respiratori
pathogen
usd
includ
reagent
suppli
assum
use
singl
filmarray
instrument
diagnosi
take
h
test
eight
specimen
list
price
eight
filmarray
respiratori
panel
kit
usd
usd
reagent
suppli
need
thu
cost
filmarray
assay
higher
previous
use
convent
method
respiratori
pathogen
test
howev
filmarray
respiratori
panel
offer
signific
advantag
accuraci
eas
use
faster
turnaround
time
less
handson
time
test
may
favor
avail
method
although
advanc
diagnost
test
improv
clinic
care
made
year
limit
remain
area
rapid
test
multipl
pathogen
need
shorten
turnaround
time
result
filmarray
system
abil
perform
highord
multiplex
test
yet
simpl
use
requir
minim
handson
time
previou
studi
shown
rapid
evolut
taiwanes
influenza
isol
term
antigen
genet
divers
may
result
epidem
strain
capac
becom
domin
strain
worldwid
chiu
et
al
lin
et
al
lin
et
al
note
data
studi
show
filmarray
system
abl
detect
new
genet
variant
influenza
viru
even
small
number
sampl
test
thu
system
could
use
firstlin
diagnost
test
sensit
accur
detect
known
respiratori
pathogen
figur
molecular
phylogenet
analysi
maximum
likelihood
method
evolutionari
histori
infer
use
maximum
likelihood
method
base
tamuranei
model
number
left
node
bootstrap
percentag
replic
bootstrap
valu
less
shown
initi
tree
heurist
search
obtain
automat
appli
neighborjoin
bionj
algorithm
matrix
pairwis
distanc
estim
use
maximum
composit
likelihood
mcl
approach
select
topolog
superior
log
likelihood
valu
tree
drawn
scale
branch
length
measur
number
substitut
per
site
evolutionari
analys
conduct
mega
shortcom
filmarray
system
detect
clinic
import
respiratori
virus
middl
east
respiratori
syndrom
coronaviru
merscov
human
avian
influenza
virus
enteroviru
differenti
human
rhinoviru
enteroviru
thu
second
detect
system
would
requir
full
diagnost
profil
need
recommend
analyt
scheme
laboratori
diagnosi
shown
figur
due
high
sensit
simplic
perform
filmarray
appli
front
line
diagnost
use
filmarray
assay
facilit
urgent
test
also
laboratori
surveil
common
viral
bacteri
respiratori
pathogen
conclus
studi
demonstr
use
highli
sensit
assay
use
clinic
sampl
feasibl
applic
worldwid
may
lead
increas
rate
diagnosi
viral
infect
improv
patient
outcom
particular
reduct
overus
antibiot
antivir
author
declar
conflict
interest
figur
schemat
illustr
workflow
detect
common
upper
respiratori
infect
pathogen
sampl
process
step
includ
viru
isol
clinic
sampl
follow
immunofluoresc
assay
ifa
identif
cytopath
effect
cpe
observ
ifa
untyp
virus
pathogen
detect
rtpcr
sequenc
